Argonaute2 mediates compensatory expansion of the pancreatic β cell
Authors
- S.G. Tattikota
- T. Rathjen
- S.J. McAnulty
- H.H. Wessels
- I. Akerman
- M. van de Bunt
- J. Hausser
- J.L.S. Esguerra
- A. Musahl
- A.K. Pandey
- X. You
- W. Chen
- P.L. Herrera
- P.R. Johnson
- D. O'Carroll
- L. Eliasson
- M. Zavolan
- A.L. Gloyn
- J. Ferrer
- R. Shalom-Feuerstein
- D. Aberdam
- M.N. Poy
Journal
- Cell Metabolism
Citation
- Cell Metab 19 (1): 122-134
Abstract
Pancreatic {beta} cells adapt to compensate for increased metabolic demand during insulin resistance. Although the microRNA pathway has an essential role in {beta} cell proliferation, the extent of its contribution is unclear. Here, we report that miR-184 is silenced in the pancreatic islets of insulin-resistant mouse models and type 2 diabetic human subjects. Reduction of miR-184 promotes the expression of its target Argonaute2 (Ago2), a component of the microRNA-induced silencing complex. Moreover, restoration of miR-184 in leptin-deficient ob/ob mice decreased Ago2 and prevented compensatory {beta} cell expansion. Loss of Ago2 during insulin resistance blocked {beta} cell growth and relieved the regulation of miR-375-targeted genes, including the growth suppressor Cadm1. Lastly, administration of a ketogenic diet to ob/ob mice rescued insulin sensitivity and miR-184 expression and restored Ago2 and {beta} cell mass. This study identifies the targeting of Ago2 by miR-184 as an essential component of the compensatory response to regulate proliferation according to insulin sensitivity.